The Israel-based company’s Exablate Neuro device uses high-intensity, focused ultrasound to thermally ablate targeted tissue, guided by continuous magnetic resonance imaging; the procedure can be performed non-invasively through an intact skull.
“This important milestone is directly attributed to the commitment and collaboration of the teams at Insightec and Siemens Healthineers, who met the challenge head-on. Expansion of MRI compatibility for Exablate Neuro substantially increases the potential reach of incisionless brain surgery for essential tremor patients,” Insightec CEO & board chair Dr. Maurice Ferré said in a press release.
Insightec said that with the clearance, its Exablate Neuro is now indicated for use with Siemen’s Healthineer’s Magnetom Skyra, Prisma and Prima[fit] MRI machines for treating patients with essential tremor.
“With the compatibility of Insightec’s innovative technology with our MRI scanners, Siemens Healthineers is staying true to its mission of delivering best-in-class diagnostic imaging with advanced therapy solutions in the neurological space. This joint development underlines our commitment to expanding precision medicine, and paving the way for offering focused ultrasound to more hospitals and patients in our worldwide network,” Siemens Healthineers magnetic resonance GM Dr. Christoph Zindel said in a prepared statement.
In July, Insightec said that it won Medicare benefit coverage for its MR-guided focused ultrasound system for the treatment of essential tremor in six new states, bringing the total number of states with Medicare coverage for its tech to 16.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.